Wei Zhen, Liu Xiaoyi, Cheng Chunming, Yu Wei, Yi Ping
Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Brain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, China.
Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Front Cell Dev Biol. 2021 Jan 12;8:603837. doi: 10.3389/fcell.2020.603837. eCollection 2020.
Metabolic reprogramming has been widely recognized as a hallmark of malignancy. The uptake and metabolism of amino acids are aberrantly upregulated in many cancers that display addiction to particular amino acids. Amino acids facilitate the survival and proliferation of cancer cells under genotoxic, oxidative, and nutritional stress. Thus, targeting amino acid metabolism is becoming a potential therapeutic strategy for cancer patients. In this review, we will systematically summarize the recent progress of amino acid metabolism in malignancy and discuss their interconnection with mammalian target of rapamycin complex 1 (mTORC1) signaling, epigenetic modification, tumor growth and immunity, and ferroptosis. Finally, we will highlight the potential therapeutic applications.
代谢重编程已被广泛认为是恶性肿瘤的一个标志。在许多对特定氨基酸成瘾的癌症中,氨基酸的摄取和代谢异常上调。在基因毒性、氧化和营养应激下,氨基酸促进癌细胞的存活和增殖。因此,靶向氨基酸代谢正成为癌症患者潜在的治疗策略。在这篇综述中,我们将系统地总结氨基酸代谢在恶性肿瘤中的最新进展,并讨论它们与雷帕霉素复合物1(mTORC1)信号传导、表观遗传修饰、肿瘤生长和免疫以及铁死亡的相互联系。最后,我们将强调潜在的治疗应用。